Deciphera Pharmaceuticals, Inc. Operating Lease Cost
Deciphera Pharmaceuticals, Inc. reported Operating Lease Cost of $6.01 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2020-12-31 was $1.32M, a 73.98% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2020-09-30 was $1.32M, a 1170.19% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2019-12-31 was $761.00K.
- Deciphera Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2019-09-30 was $104.00K.
- Deciphera Pharmaceuticals, Inc. operating lease, cost for fiscal 2023 was $6.01M, a 3.49% increase from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. operating lease, cost for fiscal 2022 was $5.81M, a 12.19% increase from fiscal 2021.
- Deciphera Pharmaceuticals, Inc. operating lease, cost for fiscal 2021 was $5.18M, a 24.26% increase from fiscal 2020.
- Deciphera Pharmaceuticals, Inc. operating lease, cost for fiscal 2020 was $4.17M, a 240.72% increase from fiscal 2019.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $6.01M 10-K · filed 2024-02-07 | |||
| 2022-12-31 | $5.81M 10-K · filed 2024-02-07 | |||
| 2021-12-31 | $5.18M 10-K · filed 2024-02-07 | |||
| 2020-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $2.65M derived: sum of 2 quarters · filed 2023-02-07 | $4.17M 10-K · filed 2023-02-07 | |
| 2020-09-30 | $1.32M 10-Q · filed 2020-11-05 | $2.84M 10-Q · filed 2020-11-05 | ||
| 2019-12-31 | $761.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $865.00K derived: sum of 2 quarters · filed 2022-02-08 | $1.07M derived: sum of 3 quarters · filed 2022-02-08 | $1.22M 10-K · filed 2022-02-08 |
| 2019-09-30 | $104.00K 10-Q · filed 2020-11-05 | $307.00K derived: sum of 2 quarters · filed 2020-11-05 | $462.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $203.00K 10-Q · filed 2019-08-02 | $358.00K 10-Q · filed 2019-08-02 | ||
| 2019-03-31 | $155.00K 10-Q · filed 2019-05-09 |